= SDRF-Proteomics: Data-dependent acquisition (DDA) Template
:sectnums:
:toc: left
:doctype: book
//only works on some backends, not HTML
:showcomments:
//use style like Section 1 when referencing within the document.
:xrefstyle: short
:figure-caption: Figure
:pdf-page-size: A4

//GitHub specific settings
ifdef::env-github[]
:tip-caption: :bulb:
:note-caption: :information_source:
:important-caption: :heavy_exclamation_mark:
:caution-caption: :fire:
:warning-caption: :warning:
endif::[]

[[status]]
== Status of this Template

This document provides a template for annotating Data-dependent acquisition (DDA) mass spectrometry experiments in SDRF-Proteomics format. This template defines additional columns that can be combined with any core template (human, vertebrates, etc.) to capture DDA-specific metadata.

**Type:** Experiment-type Template (used in combination with core templates)

**Status:** Released

**Version:** 1.1.0 - 2025-01

[[abstract]]
== Abstract

Data-dependent acquisition (DDA) is the most widely used mass spectrometry acquisition strategy for proteomics. This template captures acquisition-specific parameters that affect data quality and reproducibility: dissociation method, collision energy, fractionation, modification parameters, mass tolerances, and MS2 mass analyzer.

[[checklist]]
== Checklist

This section defines the metadata columns required and recommended for DDA experiments.

=== Recommended Columns

The following columns are RECOMMENDED for DDA experiments (in addition to the core SDRF-Proteomics requirements):

|===
|Column Name |Description |Cardinality |Ontology/CV |Example Values

|comment[dissociation method]
|Fragmentation method used
|0..1
|MS, PRIDE (children of MS:1000044)
|NT=HCD;AC=PRIDE:0000590

|comment[modification parameters]
|Post-translational modifications searched
|0..*
|UNIMOD
|NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35
|===

=== Optional Columns

The following columns are OPTIONAL but commonly used:

|===
|Column Name |Description |Cardinality |Ontology/CV |Example Values

|comment[collision energy]
|Collision energy used for fragmentation
|0..1
|Numeric value
|27, 30, normalized 27

|comment[fractionation method]
|Method used to fractionate the sample before MS
|0..1
|PRIDE (children of PRIDE:0000550)
|NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564, NT=Strong cation-exchange chromatography;AC=PRIDE:0000561

|link:../../metadata-guidelines/data-file-metadata.adoc#mass-tolerances[comment[precursor mass tolerance]]
|Mass tolerance for precursor ions in database search
|0..1
|Numeric value with unit
|10 ppm, 20 ppm

|link:../../metadata-guidelines/data-file-metadata.adoc#mass-tolerances[comment[fragment mass tolerance]]
|Mass tolerance for fragment ions in database search
|0..1
|Numeric value with unit
|0.02 Da, 20 ppm

|comment[MS2 mass analyzer]
|Mass analyzer used for MS2 acquisition
|0..1
|MS (children of MS:1000443)
|NT=orbitrap;AC=MS:1000484
|===

NOTE: For data file metadata (comment columns), use the full CV term format `NT={name};AC={accession}` when possible. This format enables automated validation and software can often determine these values from raw files.

[[example-sdrf]]
== Example SDRF File

A complete example for a fractionated DDA proteomics experiment:

|===
|source name |... |assay name |comment[proteomics data acquisition method] |comment[label] |comment[instrument] |comment[cleavage agent details] |comment[fraction identifier] |comment[fractionation method] |comment[technical replicate] |comment[dissociation method] |comment[collision energy] |comment[modification parameters] |comment[modification parameters] |comment[data file]

|liver_sample_001
|...
|DDA_liver001_F01
|Data-dependent acquisition
|label free sample
|Q Exactive HF
|NT=Trypsin;AC=MS:1001251
|1
|high-pH reversed phase
|1
|HCD
|30
|NT=Carbamidomethyl;TA=C;MT=Fixed;AC=UNIMOD:4
|NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35
|liver001_F01.raw

|liver_sample_001
|...
|DDA_liver001_F02
|Data-dependent acquisition
|label free sample
|Q Exactive HF
|NT=Trypsin;AC=MS:1001251
|2
|high-pH reversed phase
|1
|HCD
|30
|NT=Carbamidomethyl;TA=C;MT=Fixed;AC=UNIMOD:4
|NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35
|liver001_F02.raw

|liver_sample_002
|...
|DDA_liver002_F01
|Data-dependent acquisition
|label free sample
|Q Exactive HF
|NT=Trypsin;AC=MS:1001251
|1
|high-pH reversed phase
|1
|HCD
|30
|NT=Carbamidomethyl;TA=C;MT=Fixed;AC=UNIMOD:4
|NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35
|liver002_F01.raw
|===

NOTE: The `...` column indicates omitted core columns (organism, organism part, disease, biological replicate, technology type).

[[single-shot-example]]
== Single-Shot DDA Example

For high-throughput or clinical samples without fractionation:

|===
|source name |... |assay name |comment[proteomics data acquisition method] |comment[label] |comment[instrument] |comment[cleavage agent details] |comment[fraction identifier] |comment[technical replicate] |comment[dissociation method] |comment[data file]

|plasma_001
|...
|plasma001_run1
|Data-dependent acquisition
|label free sample
|Orbitrap Exploris 480
|NT=Trypsin;AC=MS:1001251
|1
|1
|HCD
|plasma_001.raw
|===

NOTE: For single-shot experiments, `comment[fractionation method]` can be omitted or set to `not applicable`.

[[tmt-dda-example]]
== TMT-Labeled DDA Example

For isobaric labeling experiments (TMT, iTRAQ):

|===
|source name |... |assay name |comment[proteomics data acquisition method] |comment[label] |comment[fraction identifier] |comment[fractionation method] |comment[dissociation method] |comment[MS2 mass analyzer] |comment[data file]

|sample_A_rep1
|...
|TMT_set1_F01
|Data-dependent acquisition
|TMT126
|1
|high-pH reversed phase
|HCD
|orbitrap
|TMT_set1_F01.raw

|sample_B_rep1
|...
|TMT_set1_F01
|Data-dependent acquisition
|TMT127N
|1
|high-pH reversed phase
|HCD
|orbitrap
|TMT_set1_F01.raw
|===

NOTE: For TMT experiments, multiple samples share the same raw file. Use `comment[label]` to distinguish channels. TMT quantification can use MS2 or MS3 acquisition—for MS3-based TMT, use https://www.ebi.ac.uk/ols4/ontologies/pride/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FPRIDE_0000646[PRIDE:0000646 (MS3 spectra)].

[[best-practices]]
== Best Practices for DDA Annotation

1. **Always specify acquisition method**: Use `comment[proteomics data acquisition method]` with `Data-dependent acquisition`.

2. **Document fragmentation method**: Use `comment[dissociation method]` to specify HCD, CID, ETD, or EThcD—these produce different fragmentation patterns and affect peptide identification.

3. **Include modification parameters**: Document all searched PTMs using `comment[modification parameters]` with UNIMOD accessions.

4. **Document fractionation**: Include `comment[fractionation method]` and properly number fractions with `comment[fraction identifier]`.

5. **Report collision energy**: Include `comment[collision energy]` when available, as it affects fragmentation quality.

6. **Specify MS2 analyzer**: Use `comment[MS2 mass analyzer]` for hybrid instruments (e.g., Orbitrap vs ion trap MS2).

7. **Report mass tolerances when known**: `comment[precursor mass tolerance]` and `comment[fragment mass tolerance]` aid data reanalysis.

[[template-file]]
== Template File

The DDA SDRF template file is available in this directory:

- link:dda-acquisition-template.sdrf.tsv[dda-acquisition-template.sdrf.tsv]

[[validation]]
== Validation

DDA SDRF files should be validated using the sdrf-pipelines tool:

[source,bash]
----
pip install sdrf-pipelines
parse_sdrf validate-sdrf --sdrf_file your_file.sdrf.tsv
----

NOTE: DDA-specific validation rules are under development.

[[authors]]
== Authors and Maintainers

This template was developed by the SDRF-Proteomics community.

For questions or suggestions, please open an issue on the https://github.com/bigbio/proteomics-metadata-standard[GitHub repository].

